Olpadronic acid
Code | Size | Price |
---|
TAR-T33793-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Olpadronic acid is a biochemical.
CAS:
63132-39-8
Formula:
C5H15NO7P2
Molecular Weight:
263.123
Purity:
0.98
SMILES:
CN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O
References
Rold?n EJ. [Pamidronate and olpadronate discoverer, Prof. Olav Maria Leonard Bijvoet passed away]. Medicina (B Aires). 2014;74(5):425-7. Spanish. PubMed PMID: 25347910.
Morelli S, Bilbao PS, Katz S, Lezcano V, Rold?n E, Boland R, Santillan G. Protein phosphatases: possible bisphosphonate binding sites mediating stimulation of osteoblast proliferation. Arch Biochem Biophys. 2011 Mar 15;507(2):248-53. doi: 10.1016/j.abb.2010.12.013. Epub 2010 Dec 15. PubMed PMID: 21167123.
Kuijpers SC, de Jong E, Hamdy NA, van Merkesteyn JP. Initial results of the treatment of diffuse sclerosing osteomyelitis of the mandible with bisphosphonates. J Craniomaxillofac Surg. 2011 Jan;39(1):65-8. doi: 10.1016/j.jcms.2010.03.014. Epub 2010 Apr 27. PubMed PMID: 20427193.
Capozza RF, Mondelo N, Reina PS, Nocciolino L, Meta M, Roldan EJ, Ferretti JL, Cointry GR. Mineralization- and remodeling-unrelated improvement of the post-yield properties of rat cortical bone by high doses of olpadronate. J Musculoskelet Neuronal Interact. 2013 Jun;13(2):185-94. PubMed PMID: 23728105.